Reduction of β-
catenin (CTNNB1) destroying complex components, for example,
adenomatous polyposis coli (APC), induces β-
catenin signaling and subsequently triggers activation of genes involved in proliferation and
tumorigenesis. Though diminished expression of APC has organ-specific and threshold-dependent influence on the development of liver
tumors in mice, the molecular basis is poorly understood. Therefore, a detailed investigation was conducted to determine the underlying mechanism in the development of liver
tumors under reduced APC levels. Mouse liver at different developmental stages was analyzed in terms of β-
catenin target genes including
Cyp2e1, Glul, and Ihh using real-time RT-PCR, reporter gene assays, and immunohistologic methods with consideration of liver zonation. Data from human livers with mutations in APC derived from patients with
familial adenomatous polyposis (FAP) were also included. Hepatocyte senescence was investigated by determining
p16(INK4a) expression level, presence of senescence-associated β-
galactosidase activity, and assessing ploidy. A β-
catenin activation of hepatocytes does not always result in β-
catenin positive but unexpectedly also in mixed and β-
catenin-negative
tumors. In summary, a senescence-inducing program was found in hepatocytes with increased β-
catenin levels and a positive selection of hepatocytes lacking
p16(INK4a), by epigenetic silencing, drives the development of liver
tumors in mice with reduced APC expression (Apc(580S) mice). The lack of
p16(INK4a) was also detected in liver
tumors of mice with triggers other than APC reduction.
IMPLICATIONS: